Home/Investors/Perceptive Advisors

Perceptive Advisors

Biotech Investor · 3 portfolio companies

Portfolio

3

Combined Value

$1.8B

Focus Areas

7

Top Stage

Phase 2

Investment Focus

Oncology Genetic Diseases Cardiovascular Ophthalmology Fibrotic Diseases Autoimmune Diseases Immunology

Portfolio Companies

Company	Stage	Valuation	Focus
Relay Therapeutics	Phase 2	$1.8B	Oncology, Genetic Diseases
LianBio	Phase 3	$34.5M	Oncology, Cardiovascular
Advanced Cellular Dynamics	Phase 1/2	—	Oncology, Autoimmune Diseases

Frequent Co-Investors

Atlas Venture1 shared BVF Partners1 shared RA Capital Management1 shared Third Rock Ventures1 shared Casdin Capital1 shared Entities associated with board members and public shareholders1 shared LifeSci Ventures1 shared